Skip to Content

TAK ALG-25 (Alogliptin Benzoate 25 mg)

Pill with imprint TAK ALG-25 is Red, Elliptical / Oval and has been identified as Alogliptin Benzoate 25 mg. It is supplied by Perrigo New York Inc..

Alogliptin is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TAK ALG-25

Alogliptin Benzoate

Imprint
TAK ALG-25
Strength
25 mg
Color
Red
Size
9.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Perrigo New York Inc.
Inactive Ingredients
mannitol, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), titanium dioxide, polyethylene glycol 8000, ferric oxide red, ferrosoferric oxide, shellac, butyl alcohol, alcohol

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
45802-0150 Perrigo Company
64764-0250 Takeda Pharmaceutical Company Limited

Get help with Imprint Code FAQs.

Related Images for "TAK ALG-25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.